• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    APIs

    USDMF Filed For Continuous Atorvastatin Calcium API Process

    PRESS RELEASE

    Dr. Reddys API Calendar Lauch 2026

    PRESS RELEASE

    Pharma Gains from Rupee`s Fall Despite Reliance on APIs

    BUSINESS STD

    Indian Pharma Giants Dr Reddy`s and Macleods Gear Up for Ozempic

    ECONOMICTIMES

    Dr. Reddy`s Launches Tegoprazan in India

    PRESS RELEASE

    Celebrating Creativity and Festivity: API Calendar Launch 2025!

    PRESS RELEASE

    Dr. Reddy’s wins CPHI & PMEC India Award for API manufacturing process

    PRESS RELEASE

    Gunjan at CPHI Webinar: Changing Dynamics of Global API Manufacturing

    PRESS RELEASE

    Dr. Reddy’s to invest Rs 700 cr in biosimilars and API: GV Prasad on investments & AI

    MONEY CONTROL

    USFDA completes inspection at Dr Reddy`s Laboratories` Bollaram API unit

    INDIANPHARMAPOST

    Dr Reddy`s Labs slips after receiving 3 observations for API plant in Telangana

    BUSINESS-STANDARD

    Dr Reddy’s Laboratories plunge post USFDA audit in Plant-5

    DSIJ

    Dr. Reddy`s Labs gets five observations from US FDA for API facility at AP

    PHARMABIZ

    Dr. Reddy`s Labs gets four observations from US FDA for Srikakulam unit

    PHARMABIZ

    Neopharma snatches Dr. Reddy`s API business as it continues global expansion

    FIERCE PHARMA

    True North in talks to buy into Glenmark’s API biz for Rs 1500 cr

    ECONOMIC TIMES

    Dr Reddy’s Lab receives EIR on its UK API unit

    INDIAINFOLINE

    Dr Reddy`s receives FDA 483 at Indian API plant

    IN PHARMATECHNOLOGY

    Dr Reddy`s gets 5 observations from US FDA for API unit at Hyderabad

    BUSINESS-STANDARD

    Aurobindo says reports inaccurate; Dr Reddy`s won`t comment on speculation

    IN PHARMATECHNOLOGIST

    Dr Reddy`s saw API revenues slide in FY Q1 2018

    IN PHARMATECHNOLOGIST

    Dr. Reddy`s remediation efforts still months away

    FIERCE PHARMA

    Dr Reddy`s gains on receiving EIR for Miryalaguda plant

    BUSINESS-STANDARD

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.